Skip to content
healthcare.dev
Get a free key

ATORVASTATIN CALCIUM

NDC 69097-945, ATORVASTATIN CALCIUM, tablet, film coated, from Cipla USA Inc.,.

Product NDC
69097-945
Status
Listed
Labeler
Cipla USA Inc.,
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205519
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-945 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
69097-945-056909709450590 TABLET, FILM COATED in 1 BOTTLE (69097-945-05)
69097-945-1269097094512500 TABLET, FILM COATED in 1 BOTTLE (69097-945-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/18fe5990-399d-416c-852f-e14974317b8b

Use it

Look up 69097-945 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-945 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-945. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.